Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes
Clinical Infectious Diseases·
- DOI
- 10.1093/cid/ciab517
- PMID
- 34086877
- PMCID
- PMC8244782
- OpenAlex
- W3169606972
- Study type
- Journal article
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Publication version
This article has a linked preprint
The relationship comes from Crossref version metadata. Compare both records because findings and wording may have changed between versions.
Open linked preprint →Why this research matters now
The findings indicate that staff vaccination in nursing homes may help protect both staff and residents from symptomatic COVID-19, provided vaccines offer some protection against infection or infectiousness, and that testing frequency recommendations may need to be tailored based on vaccine performance characteristics.
Structured evidence summary
Research question
This modeling study examined how vaccination strategies and testing approaches might affect SARS-CoV-2 transmission outcomes in nursing home settings, given limited empirical data on vaccine efficacy against infection and infectiousness.
Study design
The study employed a stochastic agent-based Susceptible-Exposed-Infectious (Asymptomatic/Symptomatic)-Recovered transmission model to simulate SARS-CoV-2 spread in a nursing home, comparing three scenarios that varied in assumptions about vaccine efficacy against infection, infectiousness, and symptoms.
Population and setting
The modeling analysis focused on nursing home residents and staff in the United States, a population included in the first phase of COVID-19 vaccination rollout.
Main findings
Increasing staff vaccination coverage reduced total symptomatic cases (combined staff and residents) across all scenarios. In scenarios assuming 50% or 90% vaccine efficacy against infection and infectiousness, higher staff coverage also reduced symptomatic cases among residents. However, in a scenario where vaccination only protected against symptoms while asymptomatic individuals remained infectious, increased staff coverage actually increased symptomatic cases among residents, though this was offset by greater reductions among staff. The modeling suggested that testing more than once weekly would be needed to reduce symptomatic cases if vaccine efficacy against infection or infectiousness was lower, or if the vaccine only protected against symptoms.
Public-health relevance
The findings indicate that staff vaccination in nursing homes may help protect both staff and residents from symptomatic COVID-19, provided vaccines offer some protection against infection or infectiousness, and that testing frequency recommendations may need to be tailored based on vaccine performance characteristics.
Important limitations
The study relies on mathematical modeling with inherent assumptions, and the limited empirical data available at the time on vaccine efficacy against infection and infectiousness necessitated modeling multiple scenarios rather than confirmed outcomes. This summary is limited to the supplied single-article abstract and metadata; full evaluation requires the original paper.
GIDS interpretation
This modeling study provides theoretical projections about potential relationships between staff vaccination coverage, resident symptomatic cases, and testing strategies in nursing home environments. The findings represent simulated outcomes under varying assumptions rather than observed surveillance data.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 12 auditable classifier relationships to diseases, places, topics, and study design.